SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,548,000 | -85.0% | 14,000 | -89.9% | 0.01% | -80.0% |
| Q2 2022 | $10,344,000 | +3.5% | 138,000 | +7.8% | 0.02% | +47.1% |
| Q1 2022 | $9,999,000 | +808.2% | 128,000 | +947.2% | 0.02% | +750.0% |
| Q4 2021 | $1,101,000 | -94.3% | 12,223 | -94.2% | 0.00% | -94.1% |
| Q3 2021 | $19,339,000 | +3814.8% | 209,118 | +3188.5% | 0.03% | +3300.0% |
| Q2 2021 | $494,000 | -94.6% | 6,359 | -90.2% | 0.00% | -96.0% |
| Q3 2020 | $9,142,000 | +95.4% | 65,098 | +123.1% | 0.02% | +56.2% |
| Q2 2020 | $4,678,000 | -3.5% | 29,176 | -54.7% | 0.02% | +14.3% |
| Q3 2019 | $4,850,000 | +408.4% | 64,392 | +926.2% | 0.01% | +250.0% |
| Q2 2019 | $954,000 | 0.0% | 6,275 | -21.6% | 0.00% | 0.0% |
| Q1 2019 | $954,000 | -66.4% | 8,000 | -69.2% | 0.00% | -69.2% |
| Q4 2018 | $2,837,000 | +55.0% | 26,000 | +5.3% | 0.01% | +44.4% |
| Q1 2018 | $1,830,000 | -66.9% | 24,700 | -79.7% | 0.01% | -71.9% |
| Q3 2017 | $5,523,000 | – | 121,767 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |